Orion Investment Company’s AbbVie ABBV Stock Holding History

Orion Investment Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.54M	Sell	6,102 -9	-0.1%	-$1.94K	0.45%	36
2026 Q1	$1.33M	Sell	6,111 -5	-0.1%	-$1.11K	0.42%	41
2025 Q4	$1.4M	Hold	6,116	–	–	0.43%	37
2025 Q3	$1.42M	Hold	6,116	–	–	0.45%	36
2025 Q2	$1.14M	Hold	6,116	–	–	0.4%	39
2025 Q1	$1.28M	Sell	6,116 -30	-0.5%	-$5.83K	0.52%	35
2024 Q4	$1.09M	Buy	6,146 +388	+7%	+$71.3K	0.44%	36
2024 Q3	$1.14M	Sell	5,758 -20	-0.3%	-$3.73K	0.44%	35
2024 Q2	$991K	Buy	+5,778	New	+$957K	0.39%	35

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Orion Investment Company's ABBV Position: Q2 2026 in Review

Orion Investment Company reduced its AbbVie (ABBV) stake by 0.15% in Q2 2026, selling an estimated $1.94K and leaving 6,102 shares worth $1.54M. The position accounts for 0.45% of the portfolio, ranked #36.

Orion Investment Company first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Orion Investment Company held 6,102 shares of AbbVie worth $1.54M as of Q2 2026.
Orion Investment Company sold 9 AbbVie shares in Q2 2026, an estimated $1.94K.
AbbVie made up 0.45% of Orion Investment Company's portfolio in Q2 2026, its #36 holding.
Orion Investment Company first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Orion Investment Company's 13F filing for Q2 2026, filed 11 Aug 2026.